Founded Year

2016

Stage

Series B | Alive

Total Raised

$60.2M

Last Raised

$40M | 2 mos ago

Mosaic Score

+130 points in the past 30 days

What is a Mosaic Score?
The Mosaic Score is an algorithm that measures the overall financial health and market potential of private companies.

About Mendel.ai

Mendel.ai is the artificial intelligence engine and technology powering Mendel Health. Mendel Health is a for-profit corporation that uses deep learning technology to sift through unstructured data in medical literature and patient health records in order to suggest evidence-based treatment options and to continuously update the results whenever a new matching trial or treatment emerges. The company is currently focused on oncology and cancer patient populations. Mendel was founded in 2016 and is based in San Jose, California.

Mendel.ai Headquarter Location

111 W St John St Suite 950

San Jose, California, 95113,

United States

(877) 620-9080

ESPs containing Mendel.ai

The ESP matrix leverages data and analyst insight to identify and rank leading companies in a given technology landscape.

EXECUTION STRENGTHMARKET STRENGTHLEADERHIGHFLIEROUTPERFORMERCHALLENGER
Healthcare / Biopharmaceuticals

Companies in this market offer alternative datasets that can supplement clinical trial data and improve the likelihood of trial success. These companies collect data from a variety of sources, such as patient registries, EHRs, insurance databases, social media, and patient research networks.

Mendel.ai named as Challenger among 15 other companies, including Datavant, Syapse, and Evidation.

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Mendel.ai's Products & Differentiation

See Mendel.ai's products and how their products differentiate from alternatives and competitors

  • Retina

    Optical Character Recognition technology

    Differentiation

    Designed specifically for healthcare, our OCR can isolate fax noise, skewed positions, highlighted text and terms that are not used outside of healthcare. OCR text is the foundation of structuring t… 

  • Subscribe to see more

    We're on a mission to enable every organization to make smarter decisions about tech. Whether it's finding a new game-changing vendor or understanding a new market, it's easier, faster and smarter with CB Insights. All made possible by the smartest, hardest-working team in tech. Subscribe to see more.

    Differentiation

    We're on a mission to enable every organization to make smarter decisions about tech. Whether it's finding a new game-changing vendor or understanding a new market, it's easier, faster and smarter with CB Insights. All made possible by the smartest, hardest-working team in tech. Subscribe to see more.

  • Subscribe to see more

    We're on a mission to enable every organization to make smarter decisions about tech. Whether it's finding a new game-changing vendor or understanding a new market, it's easier, faster and smarter with CB Insights. All made possible by the smartest, hardest-working team in tech. Subscribe to see more.

    Differentiation

    We're on a mission to enable every organization to make smarter decisions about tech. Whether it's finding a new game-changing vendor or understanding a new market, it's easier, faster and smarter with CB Insights. All made possible by the smartest, hardest-working team in tech. Subscribe to see more.

  • Subscribe to see more

    We're on a mission to enable every organization to make smarter decisions about tech. Whether it's finding a new game-changing vendor or understanding a new market, it's easier, faster and smarter with CB Insights. All made possible by the smartest, hardest-working team in tech. Subscribe to see more.

    Differentiation

    We're on a mission to enable every organization to make smarter decisions about tech. Whether it's finding a new game-changing vendor or understanding a new market, it's easier, faster and smarter with CB Insights. All made possible by the smartest, hardest-working team in tech. Subscribe to see more.

  • Subscribe to see more

    We're on a mission to enable every organization to make smarter decisions about tech. Whether it's finding a new game-changing vendor or understanding a new market, it's easier, faster and smarter with CB Insights. All made possible by the smartest, hardest-working team in tech. Subscribe to see more.

    Differentiation

    We're on a mission to enable every organization to make smarter decisions about tech. Whether it's finding a new game-changing vendor or understanding a new market, it's easier, faster and smarter with CB Insights. All made possible by the smartest, hardest-working team in tech. Subscribe to see more.

Expert Collections containing Mendel.ai

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Mendel.ai is included in 8 Expert Collections, including Clinical Trials Tech.

C

Clinical Trials Tech

326 items

Companies developing products and services to streamline drug R&D, from drug discovery, pre-clinical testing, and clinical trials.

A

Artificial Intelligence

8,694 items

This collection includes startups selling AI SaaS, using AI algorithms to develop their core products, and those developing hardware to support AI workloads.

M

Medical Devices

7,913 items

Companies developing medical devices (per the IMDRF's definition of "medical device"). Includes software, lab-developed tests (LDTs), and combination products. *Columns updated as regularly as possible.

C

Cancer

3,605 items

Companies researching, developing, or offering products & services that aid in the screening, prevention, diagnosis, management, and treatment of cancer.

D

Digital Health

12,795 items

Technologies, platforms, and systems that engage consumers for lifestyle, wellness, or health-related purposes; capture, store, or transmit health data; and/or support life science and clinical operations. (DiME, DTA, HealthXL, & NODE.Health)

C

Clinical Trials Tech Market Map

108 items

This CB Insights Tech Market Map highlights 100+ clinical trials tech companies that are addressing 8 distinct technology priorities that pharmaceutical companies and CROs face.

Latest Mendel.ai News

Mendel Raises $40 Million Series B Round to Expand its Team and Grow Product Offering

Apr 28, 2022

News provided by Share this article Share this article SAN JOSE, Calif., April 21, 2022 /PRNewswire/ --  Mendel , the leading clinical artificial intelligence and natural language processing platform, today announced it has raised $40 million in Series B funding round led by Oak HC/FT. The round includes participation from existing investor DCM, who led Mendel's Series A funding round in June 2021. This funding comes amidst surging customer demand for Mendel's AI infrastructure. The fresh capital will enable the company to expand its team of AI and engineering teams and scale the commercial organization. It will also help accelerate the release of Mendel's new, breakthrough product, Resolve, which consolidates clinical information to create a coherent longitudinal view of the patient journey. Traditionally, it takes nearly five years to manually abstract 2 million patient lives. Mendel's Resolve abstracts the same number in less than 24 hours. "The capital we have raised is a testament to the strong market fit and demand," said Karim Galil, Co-Founder and CEO of Mendel. "Our vision it to weave Mendel into the fabric of every healthcare data platform. It's exciting to partner with Oak HC/FT as we enable the healthcare ecosystem to provide better care for every patient." The healthcare industry faces immense challenges in parsing unstructured medical data that is highly valuable, but also extremely difficult and expensive to access. Mendel's solution unlocks 80% of the world's clinical data by leveraging contextual understanding to transform unstructured electronic medical record (EMR) data and clinical literature into comprehensive and compliant analytics-ready data. It abstracts data 27,000 times faster than the primarily manual methods most frequently used in clinical settings, and its output is reviewed and validated by a team of clinical experts to guarantee research-grade output. "We believe Mendel can become a mission-critical infrastructure platform for the healthcare industry," said Billy Deitch, Partner at Oak HC/FT. "Mendel's technology sets a new standard in accuracy and scalability for processing unstructured medical data and we are confident that the company will continue to lead the industry with cutting edge solutions [and delivering for their customers]. "  "Going as far back as our first investment in 2017, we've always known that Mendel's novel AI technology was going to change the face of healthcare's information infrastructure," said Hurst Lin, General Partner at DCM. "We're proud to continue to support Mendel through its next phase of growth that comes at such a critical time for the entire healthcare industry." For more information about Mendel visit Mendel.ai , and to see open positions visit Mendel.ai/careers . About Mendel Mendel is a machine that can read and understand medicine. Mendel Health is a for-profit corporation headquartered in San Jose, California that uses novel AI technology to absorb clinical data in medical literature as well as patient health records, to unlock a wide range of Real World Data applications. For more information about Mendel, visit  Mendel.ai . About OAK HC/FT  Oak HC/FT is a venture and growth equity firm investing in companies driving transformation in healthcare and fintech, two uniquely complementary and high-growth sectors. With deep domain expertise and strategic resources, Oak HC/FT partners with leading entrepreneurs at every stage, from seed to growth, to build businesses that make a measurable, lasting impact on these industries. Founded in 2014, the firm has $3.3 billion in assets under management and is headquartered in Greenwich, CT, with investors in San Francisco and Boston. Follow Oak HC/FT on  Twitter  and  LinkedIn  and learn more at  oakhcft.com . About DCM DCM is a global venture capital firm based in Silicon Valley, Beijing and Tokyo with over $4.2 billion under management and a 25-year track record of top performance. DCM has invested in more than 400 early-stage technology companies globally and provides hands-on operational guidance and a global network of business and financial resources. DCM portfolio companies have an aggregate enterprise value exceeding $250 billion including industry leading companies Bill.com, Careem (UBER), Hims & Hers, Kuaishou, Musically (TikTok) and SoFi. For more information, visit  https://www.dcm.com . Media Contact:

Mendel.ai Web Traffic

Rank
Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

Mendel.ai Rank

  • When was Mendel.ai founded?

    Mendel.ai was founded in 2016.

  • Where is Mendel.ai's headquarters?

    Mendel.ai's headquarters is located at 111 W St John St, San Jose.

  • What is Mendel.ai's latest funding round?

    Mendel.ai's latest funding round is Series B.

  • How much did Mendel.ai raise?

    Mendel.ai raised a total of $60.2M.

  • Who are the investors of Mendel.ai?

    Investors of Mendel.ai include DCM Ventures, Oak HC/FT Partners, SOSV, Mark Goldstein, BootstrapLabs and 9 more.

  • Who are Mendel.ai's competitors?

    Competitors of Mendel.ai include Vasta Global and 8 more.

  • What products does Mendel.ai offer?

    Mendel.ai's products include Retina and 4 more.

You May Also Like

Evidation Logo
Evidation

Evidation measures health in everyday life and enables anyone to participate in research and health programs. Evidation is a two-sided platform that connects individuals and enterprises. On the consumer side, the company assists individuals to participate in research including testing of digital health programs. On the enterprise side, Evidation provides biopharma, med-tech, big tech, academic institutions, professional societies, and government partners the ability to: generate evidence; and design, test, and deploy programs that motivate evidence-based action.

Syapse Logo
Syapse

Syapse develops applications that enable the use of omics profiles in diagnosing and treating patients at diagnostic companies, research institutions, medical centers, and payers. The Syapse Discovery application provides an end-to-end solution for companies and laboratories deploying next-generation sequencing-based diagnostics, from patient sample received to physician report delivered. Discovery's configurable semantic data structure enables users to bring omics data together with traditional medical information to develop and deliver diagnostic tests. The platform's open interfaces enable bioinformaticians and biologists to use their favorite computational tools and annotations.

J
Juji

Juji is building an Artificial Intelligence platform that supplies customers with empathetic virtual agents that are based on understanding people and their individuality.

Rhino Health Logo
Rhino Health

Rhino Health provides access to the extensive, dynamic real-world patient data required to develop and commercialize AI models that deliver consistent results across the diverse patient population - in a low-risk, cost-effective, highly scalable way. The company was founded in 2020 and is based in Boston, Massachusetts.

DemystData Logo
DemystData

DemystData helps financial institutions optimize customer interactions through improved access to information. The company brings together online, social, and internal company data to create more comprehensive profiles and refined customer predictions.

Redrock Biometrics Logo
Redrock Biometrics

Redrock Biometrics has developed PalmID, a touchless palm print biometric authentication solution that can be used for banking and payment. It is more secure than fingerprint and can work on any device with a camera, from phones to VR/AR to ATMs.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.